Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Stefania Bellino

Biographic Data

ID7780564
NAMEStefania Bellino
GIVEN NAMESStefania
FAMILY NAMEBellino
SIGNATUREBELLINO S
AFFILIATIONSIstituto Superiore di Sanità
ORCID0000-0003-1149-3835
VERIFIEDYes
TOTAL WORKS3
TOTAL CITATIONS0
WORKS AS AUTHOR3
WORKS AS EDITOR0
FIRST PUBLICATION YEAR2011
LATEST PUBLICATION YEAR2023
H-INDEX0
  • Brand-specific estimates of influenza vaccine effectiveness for the 2021–2022 season in Europe

    Open Access•Anke L Stuurman, Antonio Losa Carmona et al.•ARTICLE•Frontiers in Public Health•2023

    Introduction: Development of Robust and Innovative Vaccine Effectiveness (DRIVE) was a European public-private partnership (PPP) that aimed to provide annual, brand-specific estimates of influenza vaccine effectiveness (IVE) for regulatory and public health purposes. DRIVE was launched in 2017 under the umbrella of the Innovative Medicines Initiative (IMI) and conducted IVE studies from its pilot season in 2017-2018 to its final season in 2021-20…

  • Hospital discharges-based search of acute flaccid paralysis cases 2007–2016 in Italy and comparison with the National Surveillance System for monitoring the risk of polio reintroduction

    Open Access•Paola Stefanelli, Stefania Bellino et al.•ARTICLE•BMC Public Health•2019

    AFP surveillance data are the final measure of a country's progress towards polio eradication. The historical data obtained by the HDR have been useful to assess the completeness of the notification data and to identify the Regions with a low AFP ascertainment rate in order to improve the national surveillance system

  • Communication, recruitment and enrolment in the preventative and therapeutic phase I clinical trial against HIV/Aids based on the recombinant HIV-1 Tat protein

    Anna Maria Luzi, Pietro Gallo et al.•ARTICLE•AIDS Care•2011

    The role of volunteer recruitment in HIV vaccine trials has recently been considered particularly with respect to critical issues, such as motivation, psychological assessment and social impact. The preventative and therapeutic phase I trials based on the recombinant biologically active Tat vaccine candidate, sponsored in Italy by the Istituto Superiore di Sanità, included a specific centralised procedure (SCP) developed to support both the spons…

No prominent works on this page.

  • Communication, recruitment and enrolment in the preventative and therapeutic phase I clinical trial against HIV/Aids based on the recombinant HIV-1 Tat protein

    Anna Maria Luzi, Pietro Gallo et al.•ARTICLE•AIDS Care•2011

    The role of volunteer recruitment in HIV vaccine trials has recently been considered particularly with respect to critical issues, such as motivation, psychological assessment and social impact. The preventative and therapeutic phase I trials based on the recombinant biologically active Tat vaccine candidate, sponsored in Italy by the Istituto Superiore di Sanità, included a specific centralised procedure (SCP) developed to support both the spons…

  • Hospital discharges-based search of acute flaccid paralysis cases 2007–2016 in Italy and comparison with the National Surveillance System for monitoring the risk of polio reintroduction

    Open Access•Paola Stefanelli, Stefania Bellino et al.•ARTICLE•BMC Public Health•2019

    AFP surveillance data are the final measure of a country's progress towards polio eradication. The historical data obtained by the HDR have been useful to assess the completeness of the notification data and to identify the Regions with a low AFP ascertainment rate in order to improve the national surveillance system

  • Brand-specific estimates of influenza vaccine effectiveness for the 2021–2022 season in Europe

    Open Access•Anke L Stuurman, Antonio Losa Carmona et al.•ARTICLE•Frontiers in Public Health•2023

    Introduction: Development of Robust and Innovative Vaccine Effectiveness (DRIVE) was a European public-private partnership (PPP) that aimed to provide annual, brand-specific estimates of influenza vaccine effectiveness (IVE) for regulatory and public health purposes. DRIVE was launched in 2017 under the umbrella of the Innovative Medicines Initiative (IMI) and conducted IVE studies from its pilot season in 2017-2018 to its final season in 2021-20…

Environmental health (3 works) · Internal Medicine (3 works) · Medicine (3 works) · Population (3 works) · Family medicine (2 works) · Nursing (2 works) · Vaccine Coverage and Hesitancy (2 works) · Acute disseminated encephalomyelitis (1 work) · Acute flaccid paralysis (1 work) · Alternative medicine (1 work)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae